Trxade Group, Inc. Gains 114.68%

Trxade Group, Inc. (MEDS:NASDAQ) rocketted at $17.26, representing a gain of 114.7%. On Wed, Mar 06, 2024, MEDS:NASDAQ hit a New 2-Week High of $17.26. The stock appeared on our News Catalysts scanner on Wed, Mar 06, 2024 at 10:37 AM in the 'INVESTOR UPDATE' category. From Wed, Feb 21, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days

About Trxade Group, Inc. (MEDS:NASDAQ)

Trxade Group Inc engages in designing and developing business to business web-based platform which provides buying and selling opportunities for pharmacies and national suppliers of the pharmaceutical industry. The products developed by the company are trxade.com which is a web-based pharmaceutical platform for promoting and trade among independent pharmacies and suppliers, inventoryrx.com which is also a platform for promoting and trading among suppliers and manufacturers nationally, pharmabayonline which provides access to pharmaceutical data analytics to United States based independent pharmacies, and rxguru which is a service based desktop software applications for providing drug pricing and analytics.